Post-operative analgesia is one of the most permissive medication environments in the hospital: high opioid volume, legitimate clinical urgency, and a documentation culture that tolerates wide variation because pain is subjective. That combination lets diversion hide inside behavior that looks clinically ordinary. The control that surfaces it is a comparison — post-op opioid orders read against documented pain scores and the procedure actually performed. When frequent overrides, early refills, or standing PRN orders without titration notes cluster around one prescriber, unit, or administering clinician, the pattern deserves a closer look well before it becomes a reportable loss.
Building the Control: Matching Orders to Clinical Justification
The audit is a three-way reconciliation. For a defined review period, pull the post-operative controlled substance orders, the dispensing and administration transactions tied to them, and the nursing pain assessments charted in the same encounter window. Compare each against the procedure type recorded in the surgical record.
The question is narrow and answerable: does analgesic intensity match the documented clinical picture? A Schedule II opioid ordered at the top of its dosing range after a procedure your own order sets treat as low-acuity is not misconduct on its face, but it is an outlier that should carry a documented rationale. So is an administration recorded when the charted pain score was low or absent. Missing scores are as informative as high ones — an administration with no assessment before or after it breaks the clinical chain that justifies the dose.
Run the comparison at the population level first: group by procedure type, then by prescriber and administering clinician, and read the distribution rather than individual cases. The finding is the clinician whose average post-op opioid exposure runs persistently above peers performing the same procedures with no corresponding difference in documented pain scores. A single high dose is not.
Warning Signs Worth Escalating
Several patterns warrant escalation to the diversion review committee:
- Frequent automated dispensing cabinet overrides. Overrides bypass pharmacist order verification. Some are clinically justified post-op; a sustained personal rate well above unit peers, especially for opioids already on the patient profile, is not.
- Early refills and early restock requests. Repeat removals ahead of the ordered interval indicate either uncontrolled pain that was never escalated clinically or product that is not reaching the patient.
- Standing PRN orders without titration notes. A PRN opioid left at its original dose and frequency for the full post-op course, with no documented reassessment or taper, removes the checkpoint that limits cumulative exposure.
- Administration without a paired pain assessment. No pre-dose score, no post-dose reassessment, or scores entered in retrospective blocks well after the recorded administration time.
- Waste anomalies. Consistently high partial-dose waste for one clinician, waste documented without a witness, or waste volumes inconsistent with amounts dispensed and administered.
- Timing clustering. Removals concentrated at shift change, near the end of a shift, or for patients not assigned to the removing clinician.
Treat each as a question rather than a conclusion. The purpose of the audit is to identify transactions that require an explanation, then to obtain and document that explanation.
Documentation That Makes the Audit Defensible
An audit that produces no record is indistinguishable from an audit that never happened. Document the scope and date range reviewed, the data sources used, the comparison logic or thresholds applied, the outliers identified, the explanation obtained for each, and the disposition.
Two practices matter most. Record the negative findings — a reviewed period with no actionable outliers proves the control is running and establishes the baseline against which a future anomaly is measured. And record who reviewed and who concurred; findings that move toward personnel action or a regulatory report need an unbroken record showing the conclusion came from a defined process rather than individual judgment.
An Example Monthly Workflow
- Define the population: post-operative encounters closed in the prior month, grouped by procedure category.
- Extract dispensing, administration, waste, and override transactions for those encounters.
- Join them to documented pain assessments and to the surgical procedure record.
- Rank prescribers and administering clinicians on peer-comparative metrics: dose per procedure category, override rate, waste rate, and share of administrations lacking a paired assessment.
- Pull outliers above your defined threshold for case-level review, and read the chart before contacting anyone.
- Request explanations through the established channel, typically nursing or medical leadership rather than direct inquiry by the auditor.
- Record the disposition and report aggregate results to the diversion oversight committee.
Regulatory Grounding
No federal regulation prescribes a post-operative analgesia audit specifically. The obligation is general: under 21 CFR 1301.71(a), every DEA registrant must maintain effective controls and procedures to guard against theft and diversion of controlled substances. Monitoring that reaches the point of administration is how a hospital registrant shows those controls are effective rather than nominal, because administration is where the accountability chain most often breaks.
The recordkeeping requirements of 21 CFR 1304.21 and 21 CFR 1304.22 apply to the underlying transaction records the audit relies on, including that they be maintained at the registered location and be readily retrievable. If the audit identifies a confirmed theft or significant loss, 21 CFR 1301.76(b) requires DEA notification within one business day of discovery, with a DEA Form 106 filed accordingly — see the DEA Form 106 guide. Where post-op opioids are dispensed as outpatient prescriptions at discharge, the corresponding responsibility doctrine at 21 CFR 1306.04(a) applies to the pharmacist filling them.
State board and accreditation requirements may add monitoring expectations. Build the audit into your written policy set rather than running it informally; the policy templates and training materials here provide a starting structure.
Frequently Asked Questions
Q: How often should post-operative analgesia orders be audited?
A: Monthly review of the prior period works for most institutions, with the scope defined in policy. Consistency matters more than frequency — a documented schedule that is actually followed carries more weight with surveyors than an intensive review conducted irregularly.
Q: Is a high override rate alone enough to open a diversion investigation?
A: No. Override rates vary legitimately by unit acuity, verification turnaround, and staffing. The signal is a sustained personal rate above comparable peers on the same unit, particularly when it coincides with missing pain assessments or waste irregularities. Corroboration across independent signals is what justifies escalation.
Q: What if the audit finds a documentation gap rather than a drug accountability discrepancy?
A: Record it as a documentation finding and correct it through education and process change. Separating charting deficiencies from accountability discrepancies protects staff cooperation, and closing those gaps preserves the record you would need if a genuine diversion investigation followed.